COc1cccc(N2CCN(C(=O)c3ccc(C[S+]([O-])c4ccc(C)cc4)o3)CC2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?